Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Urologic Diseases clinical trials
6 of 12 indexed Urologic Diseases trials are currently recruiting.
12 US clinical trials · 6 currently recruiting
Urologic Diseases is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 2 of these trials.
The research picture
Urologic Diseases has 12 registered US clinical trials, 6 of them open to new participants right now, about 50% of the total.
- 6
- recruiting participants now
- 50%
- of trials open to enrollment
- 1
- in Phase 3–4 (later-stage)
- 2
- top sponsor: Northwestern University
Active & Recent Trials
12 total, page 1 of 1
Laser Outcomes Associated With (Holmium Laser Enucleation of the Prostate) HoLEP Procedures
Northwestern University
NCT06531473
Development of a New Canadian Endourology Group Stent Symptom Score
Centre hospitalier de l'Université de Montréal (CHUM)
NCT04909541
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Northwestern University
NCT05878951
Patient Satisfaction of Virtual vs In-Person Workup and Treatment of Lower Urinary Tract Symptoms.
Indiana University
NCT05508165
Trial for Reliability of Urodynamics SysTem
Bright Uro
NCT05694793
Safety and Feasibility Study of Autologous Engineered Urethral Constructs for the Treatment of Strictures
Wake Forest University Health Sciences
NCT03258658
INTIBIA Pivotal Study
Coloplast A/S
NCT05250908
Long Term Extension Study in Patients With Primary Hyperoxaluria
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
NCT04042402
Effects of a Cranberry Beverage on Women With Recent History of Urinary Tract Infections
Ocean Spray Cranberries
NCT01776021
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of FAST PV and mGFR Technology™
FAST BioMedical
NCT03095391
Proliposomal Intravesical Paclitaxel for Treatment of Low-Grade, Stage Ta, Non Muscle Invasive Bladder Cancer
Lipac Oncology
NCT03081858
Percutaneous Externally-Assembled Laparoscopic Urologic Surgery
Loma Linda University
NCT02811601
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 1 |
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Urologic Diseases Trial Landscape
12 indexed Urologic Diseases studies · 6 recruiting (50%).
Phase mix: 1 late (III/IV) vs 3 early (I/II).
Top sponsor: Northwestern University (2 trials), 9 others listed. 12 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Urologic Diseases?
PlainTrial tracks 12 US clinical trials for Urologic Diseases, of which 6 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Urologic Diseases?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.